Bruce I Sachs Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 weeks, 3 days ago
Bruce I Sachs has an estimated net worth of at least $35.2 million*, as of Oct. 15, 2025. They own shares of VRTX stock. They have sold 57,368 shares of VRTX stock since 2021, for an estimated $16.6 million.
Bruce I Sachs $VRTX SEC Form 4 Insider Trading
Bruce I Sachs has filed a total of 13 insider trades in $VRTX since 2021. Their most recent trade was a purchase of 1,634 shares, made on Aug 06, 2025. Their largest trade was a purchase of 15,000 shares, made on Aug 02, 2021. We estimate that they now own shares of $VRTX, worth an estimated $18.6 million.
Insider Trading at $VRTX
There have been a total of 501 insider trades reported at $VRTX since 2021, with 40,000 shares purchased and 848,601 shares sold. The most active insider traders in $VRTX stock have been David Altshuler, Bastiano Sanna, and Ourania Tatsis. The most recent trade was a sale of 694 shares reported by Jonathan Biller (EVP and Chief Legal Officer), made on Oct 02, 2025.
History of Insider Stock Trades by Bruce I Sachs
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
VRTX
|
Purchase | 1,634 | Aug 06, 2025 | Aug. 7, 2025, 4:19 p.m. |
|
VRTX
|
Purchase | 3,366 | Aug 06, 2025 | Aug. 7, 2025, 4:19 p.m. |
|
VRTX
|
Sale | 5,295 | Aug 01, 2024 | Aug. 2, 2024, 4:10 p.m. |
|
VRTX
|
Sale | 7,073 | May 22, 2024 | May 24, 2024, 4:13 p.m. |
|
VRTX
|
Sale | 11,250 | Nov 06, 2023 | Nov. 8, 2023, 5:11 p.m. |
|
VRTX
|
Sale | 1,697 | Jul 17, 2023 | July 18, 2023, 4:17 p.m. |
|
VRTX
|
Sale | 5,711 | Jul 17, 2023 | July 18, 2023, 4:17 p.m. |
|
VRTX
|
Sale | 3,842 | Jul 17, 2023 | July 18, 2023, 4:17 p.m. |
|
VRTX
|
Sale | 10,357 | Apr 12, 2023 | April 14, 2023, 4:14 p.m. |
|
VRTX
|
Sale | 8,026 | Apr 12, 2023 | April 14, 2023, 4:14 p.m. |
|
VRTX
|
Sale | 2,917 | Apr 12, 2023 | April 14, 2023, 4:14 p.m. |
|
VRTX
|
Sale | 1,200 | Jan 31, 2023 | Feb. 2, 2023, 5:14 p.m. |
|
VRTX
|
Purchase | 15,000 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
$VRTX Executives and Stock Owners with Insider Trades
-
David Altshuler, EVP, Global Research and CSO
-
Bastiano Sanna, EVP, Cell & Genetic Therapies
-
Ourania Tatsis, EVP, Chief Reg. & Quality Off.
-
Stuart A Arbuckle, EVP, COO
-
Charles F Jr Wagner, EVP & Chief Financial Officer
-
Jeffrey M Leiden, Executive Chairman
-
Reshma Kewalramani, CEO & President
-
Joy Liu, SVP, General Counsel
-
Kristen Ambrose, SVP & Chief Accounting Officer
-
Carmen Bozic, EVP and CMO
-
David Altshuler, EVP, Chief Scientific Officer
-
Edward Morrow Iii Atkinson, EVP, Chief Technical Ops. Off.
-
Jonathan Biller, EVP and Chief Legal Officer
-
Amit Sachdev, EVP Chief Patient & Ext Af Off
-
Amit Sachdev, EVP, Chief Patient Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.